A novel transgenic mouse model of the human multiple myeloma chromosomal translocation t(14;16)(q32;q23)

Cancer Res. 2011 Jan 15;71(2):339-48. doi: 10.1158/0008-5472.CAN-10-1057. Epub 2011 Jan 11.

Abstract

Multiple myeloma (MM) is a currently incurable neoplasm of terminally differentiated B cells. The translocation and/or overexpression of c-MAF have been observed in human MM. Although c-MAF might function as an oncogene in human MM, there has been no report thus far describing the direct induction of MM by c-MAF overexpression in vivo. In this study, we have generated transgenic (TG) mice that express c-Maf specifically in the B-cell compartment. Aged c-Maf TG mice developed B-cell lymphomas with some clinical features that resembled those of MM, namely, plasma cell expansion and hyperglobulinemia. Quantitative RT-PCR analysis demonstrated that Ccnd2 and Itgb7, which are known target genes of c-Maf, were highly expressed in the lymphoma cells. This novel TG mouse model of the human MM t(14;16)(q32;q23) chromosomal translocation should serve to provide new insight into the role of c-MAF in tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / metabolism
  • B-Lymphocytes / physiology
  • Chromosomes, Human, Pair 14
  • Chromosomes, Human, Pair 16
  • Disease Models, Animal*
  • Humans
  • Hypergammaglobulinemia / genetics
  • Hypergammaglobulinemia / metabolism
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / metabolism
  • Proto-Oncogene Proteins c-maf / biosynthesis
  • Proto-Oncogene Proteins c-maf / genetics*
  • Translocation, Genetic

Substances

  • MAF protein, human
  • Maf protein, mouse
  • Proto-Oncogene Proteins c-maf